Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciprian Jitaru

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Blood Reviews|February 2, 2023
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemiaDavid Kegyes, Ciprian Jitaru, Gabriel Ghiaur, et al.
Blood Reviews|November 15, 2021
Unexplained hemorrhagic syndrome? Consider acquired hemophilia A or BCatalin Constantinescu, Ciprian Jitaru, Sergiu Pasca, et al.
Journal of Clinical Medicine|October 23, 2021
The Predictive Role of Modified Early Warning Score in 174 Hematological Patients at the Point of Transfer to the Intensive Care UnitCatalin Constantinescu, Sergiu Pasca, Sabina Iluta, et al.
International Journal of Hematology|September 5, 2020
Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximabCiprian Tomuleasa, Sabina Iluta, Sergiu Pasca, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin PregnancyRadu Andrei Tomai, Sabina Iluta, Adrian Bogdan Tigu, et al.
Diagnostics (Basel, Switzerland)|August 28, 2020
Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COPSabina Iluta, Dragos-Alexandru Termure, Bobe Petrushev, et al.
Frontiers in Medicine|August 27, 2021
Mobile Health Technology for the Personalized Therapy of HemophiliaNoemi Dirzu, Ionut Hotea, Ciprian Jitaru, et al.
Journal of Cellular and Molecular Medicine|February 10, 2026
Snapshot Look at Castleman DiseaseCiprian Jitaru, Natalia Zlampa, Delia Dima, et al.
Journal of Clinical Medicine|October 13, 2021
Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral LymphomaDalma Deak-Mihaly, Sabina Iluta, Sergiu Pasca, et al.
Journal of Cellular and Molecular Medicine|June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancySabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood Reviews|February 2, 2023
Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemiaDavid Kegyes, Ciprian Jitaru, Gabriel Ghiaur, et al.
Blood Reviews|November 15, 2021
Unexplained hemorrhagic syndrome? Consider acquired hemophilia A or BCatalin Constantinescu, Ciprian Jitaru, Sergiu Pasca, et al.
Journal of Clinical Medicine|October 23, 2021
The Predictive Role of Modified Early Warning Score in 174 Hematological Patients at the Point of Transfer to the Intensive Care UnitCatalin Constantinescu, Sergiu Pasca, Sabina Iluta, et al.
International Journal of Hematology|September 5, 2020
Complete metabolic remission in an 84-year old patient with relapsed/refractory diffuse large B-cell lymphoma following combination immunotherapy with lenalidomide plus rituximabCiprian Tomuleasa, Sabina Iluta, Sergiu Pasca, et al.
Diagnostics (Basel, Switzerland)|September 28, 2024
"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin PregnancyRadu Andrei Tomai, Sabina Iluta, Adrian Bogdan Tigu, et al.
Diagnostics (Basel, Switzerland)|August 28, 2020
Clinical Remission in a 72-Year-Old Patient with a Massive Primary Cutaneous Peripheral T-Cell Lymphoma-NOS of the Eyelid, Following Combination Chemotherapy with Etoposide Plus COPSabina Iluta, Dragos-Alexandru Termure, Bobe Petrushev, et al.
Frontiers in Medicine|August 27, 2021
Mobile Health Technology for the Personalized Therapy of HemophiliaNoemi Dirzu, Ionut Hotea, Ciprian Jitaru, et al.
Journal of Cellular and Molecular Medicine|February 10, 2026
Snapshot Look at Castleman DiseaseCiprian Jitaru, Natalia Zlampa, Delia Dima, et al.
Journal of Clinical Medicine|October 13, 2021
Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral LymphomaDalma Deak-Mihaly, Sabina Iluta, Sergiu Pasca, et al.
Journal of Cellular and Molecular Medicine|June 16, 2021
Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancySabina Iluta, Sergiu Pasca, Grigore Gafencu, et al.
Pageof 2